Herbal hope: can a traditional decoction boost immunotherapy for Bone-Metastatic lung cancer?
NCT ID NCT05378334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a traditional Chinese herbal decoction (HGXJT) to standard immunotherapy can help control lung cancer that has spread to the bones. About 82 adults with a specific type of lung cancer (non-small cell, without certain gene mutations) will receive either the herbal medicine or a placebo alongside their regular treatment. The main goal is to see if the combination improves disease control rates, with follow-up scans every few months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guangdong Provincial Hospital of Traditional Chinese Medicine
RECRUITINGGuangzhou, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?